← Eichor
Study identifier: NCT06382051 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Modifying PEST for Psoriatic Arthritis Screening

Condition: Plaque Psoriasis · Psoriatic Arthritis  ·  Sponsor: Novartis Pharmaceuticals

PhaseNA
Planned participants502
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this study is to assess the impact of adding two questions and pictures to the validated PEST on the potential diagnosis of PsA in participants with moderate-to-severe plaque PsO in Canada.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  +41613241111  ·  novartis.email@novartis.com

Novartis Pharmaceuticals  ·  novartis.email@novartis.com

Always discuss trial participation with your own doctor first.

Locations (30)

Novartis Investigative SiteCalgary, Alberta, CanadaRecruiting
Novartis Investigative SiteEdmonton, Alberta, CanadaRecruiting
Novartis Investigative SiteEdmonton, Alberta, CanadaRecruiting
Novartis Investigative SiteKelowna, British Columbia, CanadaRecruiting
Novartis Investigative SiteSurrey, British Columbia, CanadaRecruiting
Novartis Investigative SiteWinnipeg, Manitoba, CanadaRecruiting
Novartis Investigative SiteFredericton, New Brunswick, CanadaRecruiting
Novartis Investigative SiteBarrie, Ontario, CanadaRecruiting
Novartis Investigative SiteGreater Sudbury, Ontario, CanadaRecruiting
Novartis Investigative SiteHamilton, Ontario, CanadaRecruiting
Novartis Investigative SiteHamilton, Ontario, CanadaRecruiting
Novartis Investigative SiteHamilton, Ontario, CanadaRecruiting

+ 18 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06382051